Target intelligence / Profile preview

Intelectin-1 (ITLN1)

Target
ITLN1
Molecular classification
Lectin (carbohydrate-binding protein), Receptor (for microbial glycans and lactoferrin), Glycoprotein
01

Overview

Intelectin-1 is a secreted glycoprotein lectin encoded by the ITLN1 gene. Also known as omentin or intestinal lactoferrin receptor, it binds specifically to exocyclic vicinal diols found on microbial carbohydrates such as galactofuranose—structures present on bacteria but absent from mammalian tissues—thus playing an important role in innate immunity at mucosal surfaces like the intestine. It also acts as a receptor for lactoferrin, an iron-binding protein involved in antimicrobial defense. Intelectin-1 forms disulfide-linked homotrimers (~120 kDa) that are N-glycosylated and secreted mainly by goblet cells within the gut epithelium but also found in vascular tissue, omental fat, heart, colon, thymus, ovary/testis. Its expression increases during inflammatory conditions such as ulcerative colitis; it modulates host-microbe interactions by binding select commensal/pathogenic bacteria within mucus layers. Additionally recognized as an adipocytokine circulating in blood plasma/serum with roles proposed in metabolic regulation and cardiovascular protection following injury through inhibition of fibrosis/hypertrophy/smooth muscle proliferation/migration/calcification while promoting revascularization.

Other names
OmentinIntestinal lactoferrin receptorHL-1HL1INTLITLNLFRhIntL
02

Mechanism of action

Not applicable for approved drugs. For experimental approaches: - Potential mechanisms include modulation of immune responses by binding to bacterial carbohydrates. - May influence inflammatory pathways via its lectin activity. - Modulation of metabolic processes as an adipocytokine.

03

Biological functions

Recognition of microbial glycans (binds galactofuranosyl residues on microorganisms)Host-microbe interaction at mucosal surfaces; part of the intestinal mucus barrierImmune response modulation (innate immunity)Regulation of inflammationInhibition of smooth muscle cell proliferation and migration after cardiovascular injury
04

Disease associations

Inflammation (upregulated in ulcerative colitis)Infection/host defense against microbes with galactofuranosyl residues in their cell wallsMetabolic disease/obesity/metabolic syndrome biomarker ("adipocytokine")Cancer biomarker for epithelioid-type malignant pleural mesothelioma; not expressed on most other cancer cells or normal mesothelial cellsCardiovascular disease (protective role post-injury)
05

Safety considerations

No notable safety concerns have been reported regarding therapeutic targeting due to lack of clinical drug development. As a circulating protein involved in host defense and metabolism, off-target effects could theoretically impact immune homeostasis or metabolic regulation if targeted therapeutically.
06

Biomarkers

Serum/plasma levels used as biomarkers for: - Metabolic risk factors/metabolic syndrome/obesity ("adipocytokine")Epithelioid-type malignant pleural mesothelioma diagnosis/prognosis marker in pleural effusion fluid

Beyond the preview

Go deeper on Intelectin-1 (ITLN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intelectin-1 (ITLN1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call